Price movement over the last 24 hours
AdaptHealth Corp vs Global X Lithium & Battery Tech ETF — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Global X Lithium & Battery Tech ETF trades at $71.72. The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | LIT | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $13.38 | $91.62 |
52-Week Low | $8.68 | $39.41 |
Enterprise Value | $3.33B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
LIT (Global X Lithium & Battery Tech ETF) trades at $76.17, down 0.47% with a bearish technical outlook. The ETF faces selling pressure from moving averages but maintains neutral oscillator readings. Recent news highlights strong momentum driven by energy storage, semiconductors, and EV demand, with the fund returning 125% from last year's lows according to 24/7 Wall Street on June 7, 2026. Key financial ratios remain undisclosed in current data.
Outlook remains mixed with technical weakness offset by strong sector catalysts. Investment opportunity lies in exposure to lithium and battery technology growth, particularly from EV and AI demand. Risks include reliance on Chinese supply chains, regulatory changes, and commodity price volatility. The upcoming dividend of $0.32 per share scheduled for July 2026 provides income potential.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →